Antibody-Based Therapy Shows Promise Against Stomach Cancer

SUNDAY, June 5, 2016 — An experimental therapy based on immune-system antibodies is helping some people with advanced stomach cancer live longer, a new study finds.
The phase 2 clinical trial, involving 161 patients, focused on an antibody called…
Source: Topamax